Advancing solutions to help the world prevent pandemics and diminish impacts of future outbreaks
SAVING LIVES BY PREVENTION
Our vision is to create the world’s epicenter for pandemic prevention and avoidance. The Center will identify and launch projects to advance pandemic preparedness, all while providing the collaboration and delivery of updated public health policy, R&D, applied technology, trials, manufacturing, and distribution of biodefense solutions.
The Center will be a
global integrator,
facilitator,
and initiative originator.
STRENGTH THROUGH COLLABORATION
The Pandemic Prevention & Biodefense Center will be stewarded by over 35 leaders from government, academia, industry, and non-profit communities that have come together to serve on our Steering Committee. Additional sponsors across all sectors are recognizing the need, seeing the opportuning, and joining with us to support and sustain the work.
The launch project of the Center is AHEAD100, an ambitious initiative to develop and stockpile monocolonal antibodies for the world's top 100 pathogens likely to cause pandemics in order to mitigate the risks and impact of future outbreaks.
AHEAD100
Antibody research is among the most critical components of pandemic response and are proven to provides prophylactic, post-exposure, and therapeutic benefits. Additionally, antibodies can be used effectively to protect vulnerable populations, frontline healthcare workers while complementing vaccine solutions.
OUR REGION CAN SECURE HEALTH
Greater Washington is the most strategic global location for a pandemic prevention initiative with more than 70 federal labs, 800 life sciences companies, the FDA, NIH/NIAID, ASPR/BARDA, DARPA, and other critical assets, in addition to its proximity to policy makers, government officials, and more than 175 world-wide embassies and diplomatic missions. Only through working together can we apply the industrial strength needed to prepare for and prevent future pandemics.
